Novel silver nanoparticle-based biomaterials for combating Klebsiella pneumoniae biofilms
Frontiers in Microbiology · 09.01.2025 · 15
DOI: 10.3389/fmicb.2024.1507274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 09.01.2025. Verfasst von Eslam Elashkar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Botany and Microbiology, Faculty of Science, Benha University, Benha, Egypt. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Klebsiella pneumoniae is a significant nosocomial pathogen that has developed resistance to multiple antibiotics, often forming biofilms that enhance its virulence. This study investigated the efficacy of a novel nanoformulation, AgNPs@chitosan-NaF, in combating K. pneumoniae biofilms.
Methods
Antimicrobial susceptibility testing was performed to assess the antibiotic resistance profile of K. pneumoniae isolates. The antibiofilm activity of AgNPs@chitosan-NaF was evaluated using crystal violet staining and scanning electron microscopy. The underlying mechanisms of action were investigated through gene expression analysis.
Results
The majority of K. pneumoniae isolates exhibited high levels of multidrug resistance. AgNPs@chitosan-NaF demonstrated superior biofilm inhibition compared to AgNPs@chitosan, significantly reducing biofilm biomass and disrupting biofilm architecture at MICs ranging from 0.125 to 1 μg/mL. Mechanistic studies revealed that the nanoformulation downregulated the expression of key biofilm-associated genes, including treC , fimA , mrkA , and ecpA . While AgNPs@chitosan-NaF exhibited a concentration-dependent cytotoxic effect on both normal and cancer cell lines, minimal cytotoxicity was observed at concentrations below 31.25 μg/mL.
Conclusion
This study highlights the synergistic effect of silver nanoparticles, chitosan, and sodium fluoride in combating K. pneumoniae biofilms. The nanoformulation, AgNPs@chitosan-NaF, emerges as a promising therapeutic strategy to address the challenge of multidrug-resistant bacterial infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Botany and Microbiology, Faculty of Science, Benha University, Benha, Egypt.
- Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
- Institute of Nanoscience and Nanotechnology, Kafrelsheikh University, Kafr ElSheikh, Egypt.
- Department of Bacteriology, Immunology, and Mycology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.
- Laboratory of Biotechnology, Department of Microbiology, Agricultural Research Center, Animal Health Research Institute, Zagazig, Egypt.
Zitieren
APA
Elashkar, E., Alfaraj, R., El-Borady, O. M., Amer, M. M., Algammal, A. M., & El-Demerdash, A. S. (2025). Novel silver nanoparticle-based biomaterials for combating Klebsiella pneumoniae biofilms. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1507274
Vancouver
Elashkar E, Alfaraj R, El-Borady OM, Amer MM, Algammal AM, El-Demerdash AS. Novel silver nanoparticle-based biomaterials for combating Klebsiella pneumoniae biofilms. Frontiers in Microbiology. 2025;15. doi:10.3389/fmicb.2024.1507274
BibTeX
@article{Elashkar2025,
author = {Elashkar, Eslam and Alfaraj, Rihaf and El-Borady, Ola M and Amer, Mahmoud M and Algammal, Abdelazeem M and El-Demerdash, Azza S},
title = {Novel silver nanoparticle-based biomaterials for combating Klebsiella pneumoniae biofilms},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {15},
doi = {10.3389/fmicb.2024.1507274}
}
EUVIMED